Assessing the evidence on remdesivir was written by Troeseid, Marius;Hites, Maya;Barratt-Due, Andreas;Ader, Florence;Yazdanpanah, Yazdan. And the article was included in Lancet Infectious Diseases in 2021.SDS of cas: 2492423-29-5 The following contents are mentioned in the article:
A review on remedesivir remains a controversial treatment for covid-19. ACTT-1 showed reduced time to recovery with remdesivir and improvement on an eight point ordinal scale. Mostly, based on this trial USFDA approved emergency use of remdesivir for patients with covid-19. This decision was widely contested because of paucity of clin. significant benefits on mortality. This study involved multiple reactions and reactants, such as ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5SDS of cas: 2492423-29-5).
((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5) belongs to tetrahydrofuran derivatives. Tetrahydrofuran and dihydrofuran form the basic structural unit of many naturally occurring scaffolds like gambieric acid A and ciguatoxin, goniocin, and some biologically active molecules. Tetrahydrofuran (THF) is primarily used as a precursor to polymers including for surface coating, adhesives, and printing inks.SDS of cas: 2492423-29-5
Referemce:
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem